| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Mar-31-10 | Mar-31-09 | Mar-31-08 | Mar-31-07 |
| | 10-K | 10-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Sales and service revenue | | | | | | 171.4 | 130.1 | 105.9 |
| Healthcare services revenue | | | | | 85.8 | | | |
| Other | | | | | 85.4 | | | |
| Total revenues [+] | 179.4 | 152.4 | 114.4 | 177.9 | 171.2 | 171.4 | 130.1 | 105.9 |
| Products | | | | | 85.4 | | | |
| Services | | | | | 85.8 | | | |
| Healthcare | 179.4 | 152.4 | 114.4 | | | | | |
| Revenue growth [+] | 17.7% | 33.3% | -35.7% | | -0.1% | 31.8% | 22.8% | 16.6% |
| Sales and service revenue | | | | | | 31.8% | 22.8% | |
| Cost of goods sold [+] | 0.0 | 0.0 | 0.0 | 52.4 | 78.2 | 136.1 | 99.5 | 84.4 |
| Cost of product sales | | | | | 62.0 | | | |
| Gross profit | 179.4 | 152.4 | 114.4 | 125.5 | 93.0 | 35.3 | 30.6 | 21.5 |
| Gross margin | 100.0% | 100.0% | 100.0% | 70.5% | 54.3% | 20.6% | 23.5% | 20.3% |
| Selling, general and administrative [+] | 10.5 | 7.5 | 5.1 | 3.8 | 3.5 | 27.2 | 22.2 | 16.9 |
| Sales and marketing | | | | | | 13.3 | 12.2 | 9.9 |
| General and administrative | | | | | | 13.9 | 10.1 | 6.9 |
| Equity in earnings | -1.2 | 1.0 | 1.1 | | | | | |
| Other operating expenses | 155.8 | 128.0 | 98.4 | 111.1 | 71.5 | | | |
| EBITDA [+] | 12.0 | 18.0 | 11.9 | 14.7 | 18.0 | 11.8 | 11.5 | 7.9 |
| EBITDA growth | -33.3% | 50.7% | -18.6% | | 52.8% | 2.2% | 45.6% | 128.4% |
| EBITDA margin | 6.7% | 11.8% | 10.4% | 8.2% | 10.5% | 6.9% | 8.8% | 7.5% |
| Depreciation and amortization | 10.5 | 7.5 | 5.1 | 4.0 | 3.5 | 3.6 | 3.2 | 3.3 |
| EBIT [+] | 1.5 | 10.5 | 6.8 | 10.7 | 14.4 | 8.2 | 8.3 | 4.6 |
| EBIT growth | -85.5% | 55.0% | -36.4% | | 76.6% | -2.2% | 79.5% | 744.5% |
| EBIT margin | 0.9% | 6.9% | 5.9% | 6.0% | 8.4% | 4.8% | 6.4% | 4.4% |
| Interest expense, net [+] | 1.3 | -0.4 | -0.2 | 0.1 | -0.5 | -0.7 | 2.4 | 0.5 |
| Interest expense | 2.3 | 0.5 | 0.6 | 0.8 | 1.0 | 1.0 | 3.6 | 0.8 |
| Interest income | 1.0 | 0.8 | 0.8 | 0.6 | 1.5 | 1.7 | 1.2 | 0.2 |
| Other income (expense), net | 0.1 | 0.0 | -0.1 | 0.1 | -0.6 | -1.2 | -0.2 | 0.1 |
| Pre-tax income | 0.4 | 10.9 | 6.9 | 10.6 | 14.3 | 7.7 | 5.7 | 4.2 |
| Income taxes | -6.5 | -6.8 | -3.7 | 4.3 | 6.1 | 2.7 | 2.0 | 1.2 |
| Tax rate | | | | 40.3% | 42.6% | 35.1% | 35.8% | 28.8% |
| Earnings from continuing ops | -6.1 | 4.1 | 3.2 | 6.3 | 8.2 | 5.0 | 3.7 | 3.0 |
| Earnings from discontinued ops | | | | | | | | 2.7 |
| Net income | -6.1 | 4.1 | 3.2 | 6.3 | 8.2 | 5.0 | 3.7 | 5.7 |
| Net margin | -3.4% | 2.7% | 2.8% | 3.6% | 4.8% | 2.9% | 2.8% | 5.4% |
| |
| Basic EPS [+] | ($0.36) | $0.25 | $0.20 | $0.42 | $0.56 | $0.34 | $0.32 | $0.29 |
| Growth | -246.0% | 26.0% | -52.4% | | 63.3% | 7.2% | 10.9% | 1602.7% |
| Diluted EPS [+] | ($0.36) | $0.23 | $0.18 | $0.38 | $0.51 | $0.31 | $0.27 | $0.26 |
| Growth | -258.1% | 25.6% | -51.8% | | 64.1% | 13.3% | 6.8% | 1514.9% |
| |
| Shares outstanding (basic) [+] | 16.8 | 16.4 | 16.1 | 15.2 | 14.6 | 14.4 | 11.4 | 10.3 |
| Growth | 2.6% | 1.4% | 6.2% | | 1.2% | 26.7% | 10.5% | 4.9% |
| Shares outstanding (diluted) [+] | 16.8 | 17.7 | 17.4 | 16.6 | 16.1 | 16.0 | 13.4 | 11.6 |
| Growth | -5.2% | 1.8% | 4.9% | | 0.7% | 19.9% | 14.8% | 10.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |